Showing results (141-150 of 3,348) with videos related to
Sort By:
Pageof 335
Pharmacoeconomics|June 10, 2015
Preventing Obesity in the USA: Impact on Health Service Utilization and CostsMichele Cecchini, Franco SassiPharmacoeconomics|June 13, 2015
Evaluating the Generalisability of Trial Results: Introducing a Centre- and Trial-Level Generalisability IndexAdrian Gheorghe, Tracy Roberts, Karla Hemming, et al.Pharmacoeconomics|May 11, 2015
Adjusting for Baseline Covariates in Net Benefit Regression: How You Adjust MattersWanrudee Isaranuwatchai, Maureen Markle-Reid, Jeffrey S HochPharmacoeconomics|June 11, 2020
Cost-Utility Analysis of Ravulizumab Compared with Eculizumab in Adult Patients with Paroxysmal Nocturnal HemoglobinuriaThomas O'Connell, Marric Buessing, Scott Johnson, et al.Pharmacoeconomics|August 18, 2021
Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung CancerMartijn J H G Simons, Valesca P Retèl, Bram L T Ramaekers, et al.Pharmacoeconomics|March 8, 2005
The friction-cost method : replacement for nothing and leisure for free?Werner B F Brouwer, Marc A KoopmanschapPharmacoeconomics|March 8, 2005
The impact of anaemia and its treatment on employee disability and medical costsErnst Berndt, William Crown, Joel Kallich, et al.Pharmacoeconomics|March 8, 2005
Memantine: a pharmacoeconomic review of its use in moderate-to-severe Alzheimer's diseaseGreg L Plosker, Katherine A Lyseng-WilliamsonPharmacoeconomics|February 28, 2004
Screening, prevention and socioeconomic costs associated with the treatment of colorectal cancerAlberto Redaelli, Carole W Cranor, Gary J Okano, et al.Pageof 335